A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center
Manju Sengar(Homi Bhabha National Institute), M.A. Muckaden(Homi Bhabha National Institute), Tanuja Shet(Tata Memorial Hospital), Reena Nair(Tata Medical Center), Siddharth Laskar(Homi Bhabha National Institute), Amol Akhade(Tata Memorial Hospital), Hari Menon(Tata Memorial Hospital), Sumeet Gujral(Homi Bhabha National Institute)
Cited by 13
Related Papers
Consolidation Radiation After Complete Remission in Hodgkin's Disease Following Six Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy: Is There a Need?
|Journal of Clinical Oncology|2003|202
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
|The Lancet Oncology|2021|170
Lymphoma of the Gastrointestinal Tract
|Unknown|2022|146
Barriers in access to oncology drugs — a global crisis
|Nature Reviews Clinical Oncology|2022|122
Common Sense Oncology: outcomes that matter
|The Lancet Oncology|2023|101